BIOVECTRA Reportedly Trimmed Workforce in March 2026
What’s Happening at BIOVECTRA?
Samfiru Tumarkin LLP is investigating reports that BIOVECTRA has cut jobs in March 2026.
Our employment lawyers are following up with multiple employees and reviewing the severance offers that they’ve received from the PEI-based pharmaceutical company.
In 2024, BIOVECTRA was acquired by California-based Agilent Technologies for $1.25 billion.
More BIOVECTRA Layoff Coverage
For a full overview of layoffs at BIOVECTRA and the rights that non-unionized employees in Canada have in this situation, see our BIOVECTRA Layoffs & Severance Guide.
Disclaimer: The materials above are provided as general information about the rights of non-unionized employees in Canada. It is not specific to any one company and SHOULD NOT be read as suggesting any improper conduct on the part of any specific employer, or a relationship between Samfiru Tumarkin LLP and a specific employer.